Provider Policy Notifications
This page contains notifications for clinical policies that have future effective dates. For current policies, visit the Clinical Policies page.
Policies effective 4/1/2026
- Allergy Testing and Therapy (PDF) (CP.MP.100)
- Bronchial Thermoplasty (PDF) (CP.MP.110)
- Cardiac Biomarker Testing for Acute MI (PDF) (CP.MP.156)
- Drugs of Abuse: Definitive Testing (PDF) (CP.MP.50)
- EEG in Evaluation of Headache (PDF) (CP.MP.155)
- Endometrial ablation (PDF) (CP.MP.106)
- Evoked Potential Testing (PDF) (CP.MP.134)
- Excimer Laser Therapy for Skin Conditions (PDF) (CP.MP.123)
- Facility Based Sleep Studies for Obstructive Sleep Apnea (PDF) (CP.MP.248)
- Fecal Microbiota Transplantation (PDF) (WA.CP.MP.515)
- H. Pylori Testing (PDF) (CP.MP.153)
- Holter Monitors (PDF) (CP.MP.113)
- Homocysteine Testing (PDF) (CP.MP.121)
- Low-Frequency Ultrasound and Noncontact Normothermic Wound Therapy (PDF) (CP.MP.139)
- Pediatric Oral Function Therapy (PDF) (CP.MP.188)
- Skin Substitutes for Chronic Wounds (PDF) (CP.MP.185)
- Stem Cell Therapy for Musculoskeletal Conditions (PDF) (WA.CP.MP.526)
- Thyroid Hormones and Insulin Testing in Pediatrics (PDF) (CP.MP.154)
- Transplant Service Documentation Requirements (PDF) (CP.MP.247)
- Vitamin D Testing (PDF) (CP.MP.152)
- Wireless Motility Capsule (PDF) (CP.MP.143)
Policies effective 5/1/2026
- Applied Behavioral Analysis Documentation Requirements (PDF) (CP.BH.105)
- Biofeedback (PDF) (CP.MP.168)
- Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF) (CP.MP.180)
- Obstetrical Home Health Care Programs (PDF) (CP.MP.91)
- Outpatient Oxygen Use (PDF) (CP.MP.190)
- Peripheral and Percutaneous Electrical Nerve Stimulation (PDF) (WA.CP.MP.117)
- Skin Substitutes for Chronic Wounds (PDF) (CP.MP.185)
Policies effective 6/1/2026
- Ultrasound in Pregnancy (PDF) (WA.CP.MP.38)
Policies effective 4/1/2026
- Allergy Testing and Therapy (PDF) (CP.MP.100)
- Bronchial Thermoplasty (PDF) (CP.MP.110)
- Cardiac Biomarker Testing for Acute MI (PDF) (CP.MP.156)
- Drugs of Abuse: Definitive Testing (PDF) (CP.MP.50)
- EEG in Evaluation of Headache (PDF) (CP.MP.155)
- Endometrial ablation (PDF) (CP.MP.106)
- Evoked Potential Testing (PDF) (CP.MP.134)
- Excimer Laser Therapy for Skin Conditions (PDF) (CP.MP.123)
- Fecal Microbiota Transplantation (PDF) (WA.CP.MP.515)
- H. Pylori Testing (PDF) (CP.MP.153)
- Holter Monitors (PDF) (CP.MP.113)
- Homocysteine Testing (PDF) (CP.MP.121)
- Pediatric Oral Function Therapy (PDF) (CP.MP.188)
- Stem Cell Therapy for Musculoskeletal Conditions (PDF) (WA.CP.MP.526)
- Thyroid Hormones and Insulin Testing in Pediatrics (PDF) (CP.MP.154)
- Transplant Service Documentation Requirements (PDF) (CP.MP.247)
- Vitamin D Testing (PDF) (CP.MP.152)
Policies effective 5/1/2026
- Applied Behavioral Analysis Documentation Requirements (PDF) (CP.BH.105)
- Peripheral and Percutaneous Electrical Nerve Stimulation (PDF) (WA.CP.MP.117)
Policies effective 6/1/2026
- Ultrasound in Pregnancy (PDF) (CP.MP.38)